Document:

Exhibit 10.48
                                    AGREEMENT

         This  Agreement,  dated  June  29,  2000, is  between  Surgical  Safety
Products,  Inc., a New York  corporation  ("Oasis")  and AORN,  Inc., a New York
corporation ("AORN"). The parties agree to the following terms and conditions.

         WHEREAS,  AORN has and will  develop  certain  materials  described  on
Exhibit 1 ("AORN  Deliverables") for use by health care professionals and health
care facilities;

         WHEREAS, Oasis wishes to market its products and services, and those of
others which may be similar in nature to the AORN deliverables contained herein,
to  perioperative  nurses,  perioperative  technologists,   and  operating  room
decision  makers via its various Oasis  delivery  channels which include but are
not limited to TouchPort  kiosks,  CD-ROM's,  and the Internet ("Oasis System");
add  valuable  content  to its Oasis  System;  and earn  income to  develop  its
business model;

         WHEREAS, AORN wishes to increase its membership,  increase the usage of
the AORN  Deliverables;  and  enhance  the value of AORN as an  information  and
solution  provider to operating room supervisors,  leaders,  managers and others
who need perioperative data.

         Now,  therefore,  in  consideration of the mutual promises set forth in
this Agreement as well as other good and sufficient  consideration,  the parties
agree as follows:

     1. AORN Obligations:  AORN shall be responsible for the following under the
terms of this agreement:

     A.   Develop  and  deliver to Oasis at AORN's sole cos and expense the AORN
          Deliverables  described  on  Exhibit 1 to this  Agreement.  These AORN
          Deliverables  shall be provided to Oasis  within  fifteen (15) days of
          the  execution  of this  Agreement,  with  the  exception  of the AORN
          Surgical  Knowledgebase,  the AORN  Journal and the AORN  Journal Home
          Studies.  Delivery of the Surgical  Knowledgebase,  AORN Journal,  and
          AORN Journal Home Studies  shall be as set forth on Exhibit 1. Updates
          will be provided to Oasis by AORN at mutually agreed times.

     B.   Grant Oasis a  non-exclusive  license to use specified AORN databases,
          logos, trademarks and copyrighted materials ("Intellectual  Property")
          subject to the terms and  conditions  of this  Agreement.  Such use is
          limited to the marketing and  promotion of AORN  Deliverables  and the
          Oasis system by Oasis, as approved by AORN.

     C.   Provide certain marketing  opportunities to Oasis by providing up to a
          $75,000 credit for advertising and promotion  during the first year of
          this  agreement,  and for each  contract  year  thereafter  when Oasis
          payments to AORN for licensing  fees,  usage fees,  and contact hours,
          for the preceding  year are a minimum  $375,000.  If Oasis payments to
          AORN for licensing  fees,  usage fees,  and contact hours is less than
          $375,000

                                       -1-

<PAGE>

          during any contract year, the advertising and promotion credit for the
          following contract year will be set at 20% of the amount paid to AORN.
          This  credit is to be used by Oasis to promote  the AORN  Deliverables
          and Oasis  System in the AORN  Journal,  the SSM  Supplement,  the SSM
          Online web site, OR Product Directory, and AORN Online. Oasis may also
          purchase  additional  advertising  space  from  AORN at the  60x  rate
          published in the then current AORN rate card. The parties may mutually
          agree to additional marketing opportunities.

     D.   Provide a liaison from the AORN  Publications  Department  to serve as
          AORN's   representative  to  Oasis  and  provide  project   management
          assistance.   Such  person  shall  also  assist  Oasis  in  developing
          marketing concepts and content production for the AORN Deliverables.

     E.   Be responsible  for developing and updating the AORN  Deliverables  as
          well as any  disclaimer  information  concerning  use or misuse of the
          AORN  Deliverables.  Deliverables  will contain  disclosure/disclaimer
          that  Oasis  has  no  responsibility  or  liability  for  the  content
          contained  therein.  The  disclosure/disclaimer  must be  approved  by
          Oasis.

     2. Oasis Obligations: Oasis shall be responsible for the following:

     A.   Providing  the  necessary  hardware and software  associated  with the
          Oasis System at Oasis sole cost and expense to enable  integration  of
          the  AORN  Deliverables  into  the  Oasis  System  and  to  provide  a
          co-branded  ("AORN/Oasis")  module, with Internet access, on the Oasis
          System.

     B.   Assign a project  manager to  coordinate,  track and manage the use of
          the AORN Deliverables via the Oasis System.

     C.   Develop  a link from the Oasis  system  to  AORN's  online  membership
          application  and promote AORN  membership on the Oasis  system.  Oasis
          will be  entitled  to a $30  one-time  payment for each new member who
          joins  AORN from the Oasis  system.  AORN will  provide  Oasis with an
          accounting  each quarter  reflecting  those new  memberships for which
          Oasis will be entitled to its payment.

     D.   Subject  to  authorization  from  users of the Oasis  System,  provide
          copies of data,  reports and other  reasonably  necessary  information
          generated  by the Oasis System to AORN for use by AORN in updating and
          developing AORN Deliverables.

     E.   Develop marketing and promotional  materials for the AORN Deliverables
          on the Oasis  System  subject to the prior  written  approval of AORN.
          AORN will not withhold approval unreasonably.  Such materials shall be
          submitted to AORN at least ten (10) business days prior to the date of
          use.  AORN shall  have five (5)  business  days after  receipt of such
          materials to either approve or disapprove  their use. If AORN does not
          take action within those five (5) business days,  the materials  shall
          be deemed approved.

                                       -2-

<PAGE>

     F.   Be  solely  responsible  for all costs and  expenses  associated  with
          marketing  its products and services to its customers  including,  but
          not limited to, the  distribution of Oasis Touchports and costs of the
          hardware,  networking,  connectivity and servicing of the network. All
          management,  support  and  updating  of the  network  will be the sole
          responsibility of Oasis.

     G.   Provide a quarterly  accounting,  and an audited annual report, of all
          usage of the AORN Deliverables through the Oasis System.

     H.   Report  customer   feedback   including   complaints  and  compliments
          concerning the AORN Deliverables on a periodic basis, but no less than
          quarterly.

         3.  License  &  Usage  Fees:   AORN  and  Oasis  agree  that  the  AORN
Deliverables  will be licensed to Oasis pursuant to the fee and Usage  schedules
set forth on Exhibits 2 to this  Agreement.  The total  annual  license fees and
contact hours for the first year of this Agreement total  $117,000.  This amount
is considered  earned and due to AORN upon the signing of this Agreement.  Under
no circumstances,  including  termination by Oasis, will Oasis claim any refunds
or  reimbursements  of these fees.  Oasis agrees to pay AORN one-half of the one
hundred  seventeen  thousand  dollars  ($117,000),  or fifty eight thousand five
hundred  dollars  ($58,500)  within  thirty  (30)  days  of  execution  of  this
Agreement. The balance of the first year's licensing and contact hour fees shall
be paid in two equal installments on March 1, 2000 and June 1, 2000. Payments in
excess of ten (10) days  after the due date will be  assessed a $25 per day late
fee.

         The Usage Fees set forth on Exhibit 2 will be  calculated  (based  upon
the number of Users) commencing ninety (90) days after the online publication by
Oasis of each of the particular AORN Deliverables.  A "User" shall be defined as
anyone who  accesses any of the AORN  deliverables.  If a User access any of the
AORN  Deliverables in any quarter,  that User shall be counted once as a user of
that particular  Deliverable for the purpose of calculating the Usage Fee due to
AORN.  All such users shall be added together to determine the Usage Fee due for
that quarter.  Usage Fees will be due and payable on April 31, July 31,  October
31, and January 31 during each year of the Agreement.  Payment of the Usage Fees
shall be incurred as soon as Oasis system users have online access through Oasis
to a particular AORN Deliverable. Once Oasis has paid $1,426,000 in any contract
year for the annual license and quarterly usage fees, no additional fees will be
due for that year. A contract  year begins on July 1 and ends on June 30 of each
year.

         4a.  Recovery of File Conversion  Costs:  AORN will reimburse Oasis for
50% of the cost of converting the AORN Deliverables to XML, HTML, databases,  or
other format necessary for Oasis to implement access to the AORN Deliverables on
the Oasis  System.  Any  amounts  paid under this  paragraph  shall  require the
submission of invoices from Oasis  describing the services and costs  associated
therewith.  In no event shall such reimbursement from AORN exceed $50,000 during
the term of this  Agreement.  Oasis will itemize and report all file  conversion
costs it would like rebated from AORN.

         4b.      Recovery of CE Web Enablement Costs:  AORN will also reimburse
Oasis up to $10,000 per year, to pay for the cost of web enabling the Home Study
Courses, the SRPG Study

                                       -3-

<PAGE>

Guide. This  reimbursement is separate and aside from the  reimbursements  under
"4a".  Oasis will  itemize  and report  all web  enablement  costs it would like
rebated  from AORN.  Any amounts  paid under this  paragraph  shall  require the
submission of invoices from Oasis  describing the services and costs  associated
therewith. If the usage fees paid by Oasis to AORN for any quarter are less than
$5,000,  AORN shall not be obligated to make these  payments.  Payments  will be
made based on invoices  generated from Oasis.  Payments cannot exceed 50% of the
license and usage fees paid to AORN in any quarter.

         5.  Continuing  Education:  Oasis  agrees to clearly  designate  all CE
Courses  provided by AORN as AORN CE Courses and will display a copyright notice
and/or credit line  throughout  the Content.  The  following  language is deemed
approved and shall be used by Oasis throughout the content:  "AORN  (Association
of  periOperative  Registered  Nurses) is accredited as a provider of continuing
education  in nursing  by the  American  Nurses  Credentialing  Center's  (ANCC)
Commission  on  Accreditation.  AORN  recognizes  this  activity  as  continuing
education for registered  nurses.  This  recognition does not imply that AORN or
the ANCC  Commission  on  Accreditation  approves or endorses any product.  AORN
maintains  the  following  state  board of  nursing  provider  numbers:  Alabama
Provider #ABNP0075;  California Provider #BRN00667;  Florida Provider #FBN 2296;
and Kansas Provider  #LT0114-0316."  Oasis is hereby granted a  nontransferable,
non-exclusive  right to use  AORN's  trademarks  and  logos for the  purpose  of
identifying the origin of the Content. These trademarks and logos may be used by
Oasis, in its sole discretion,  in connection with the Content on the Sites, and
in any form, format,  forum, media, medium, means or method by which the Content
is delivered, and marketing and advertising materials therefor subject to AORN's
approval,  not to be  unreasonably  withheld.  The use of AORN's  trademarks and
logos as set forth herein is subject to the limitations set forth in Section

         6.  Termination:  This Agreement shall be for a term of thirty-six (36)
months  commencing  effective  July 1, 2000,  and  terminating on June 30, 2003,
("Expiration  Date").  Either party may terminate this  Agreement  without cause
upon one hundred eighty (180) days notice to the other party at anytime.

If this Agreement is terminated  without cause by AORN,  Oasis shall be entitled
to a  prorated  refund  of any  license  and user  fees  paid by  Oasis  but not
realized, except as specified in section 3, "License & Usage Fees".

If Oasis gives notice that they are  terminating  this Agreement  without cause,
then AORN will not be obligated to fulfill its obligations  under section "1.C."
and no additional advertising and promotion credit will be due Oasis.

This Agreement may be terminated  before the Expiration Date by either party for
cause as defined below  provided that the breaching  party has received at least
sixty days (60) written notice of the breach and has been given thirty days (30)
from the date of such notice to remedy the breach to the breached party.

                                       -4-

<PAGE>

         "Termination for cause" is defined as follows:

     a.   A breach by either party of any of their respective obligations as set
          forth in this Agreement;
     b.   Failure by Oasis to make any payment of monies to AORN when due;
     c.   Either  party  ceases or  threatens  to cease to  function  as a going
          concern,  becomes  insolvent,  makes an assignment  for the benefit of
          creditors,  files a petition  in  bankruptcy,  permits a  petition  in
          bankruptcy  to be filed against it, admits in writing its inability to
          pay its debts as they become due,  or has a receiver  appointed  for a
          substantial part of its assets or stock;
     d.   Misuse or  misrepresentation  of the  Intellectual  Property by either
          AORN or Oasis of the other party

         Upon termination by either party, the parties' respective obligation to
surrender all Intellectual Property, Confidential Information, AORN Deliverables
and  associated  materials as well as any other terms and  conditions  which are
intended to survive this contract shall continue in full force and effect.  Upon
termination,  Oasis shall surrender any and all right,  title or interest in the
AORN  Deliverables  as  well as in all  Confidential  Information  and the  AORN
Intellectual Property. Upon termination, AORN shall surrender any and all right,
title  or  interest  in  the  Oasis  Confidential   Information  and  the  Oasis
Intellectual Property

         7.  Additional  Development:  The  parties  acknowledge  that  the AORN
Deliverables  product described in this Agreement is limited to the inclusion of
AORN  Deliverables into the Oasis System and that all other programs of AORN and
Oasis are separate and distinct. The parties reserve the right to develop any or
all of their other programs as they may determine in their sole discretion.  The
parties  acknowledge  that  they  each  have  a  proprietary  interest  in  such
additional  programs and that neither  party will do anything to interfere  with
the other party's development or marketing of such programs.

         8. Financial Records & Accounting: The parties agree that the financial
records and  accounts  concerning  the payment of license and usage fees to AORN
for the AORN Deliverables  shall be available to AORN at anytime upon reasonable
notice to Oasis.

         9.   Ownership  &  Control  of  AORN   Intellectual   Property:   "AORN
Intellectual  Property" means all of the names,  logos, and trademarks which are
owned by or licensed  by AORN to AORN as well as any  information  or  materials
including, but not limited to, copyrighted materials,  databases and any related
programs together with all intangible rights associated therewith whether or not
included in the AORN  Deliverables.  Oasis acknowledges and agrees that AORN has
and will invest  substantial  time, money and other resources in the development
of the  AORN  Deliverables  as  well as all  other  AORN  Intellectual  Property
including  derivative works of any kind. Oasis acknowledges  AORN's ownership of
its AORN  Deliverables and AORN  Intellectual  Property as well as all licensing
and  copyrights  to  any  materials  developed  in  conjunction  with  the  AORN
Deliverables.  All such  materials  developed as a part of the Oasis System will
have  AORN's  logo or name and AORN will have  on-going  use of such  materials.
Oasis  agrees  that it will place the  appropriate  copyright,  disclosure,  and
disclaimer statements on all AORN content used in the Oasis system.

                                       -5-

<PAGE>

Oasis agrees it d shall not do anything to  invalidate  any of AORN's rights and
licenses.  Nothing contained in this Agreement shall give Oasis any right, title
or interest in the AORN Deliverables or AORN Intellectual Property.  Oasis shall
not use the AORN Deliverables,  AORN Intellectual Property, or any part thereof,
as a part of Oasis's  corporate or trade name or the  corporate or trade name of
any parent, subsidiary,  associated, affiliated or related company. Oasis agrees
that it will not take any action  that would  create any  confusion  in the AORN
Intellectual Property.  Oasis shall not assign, transfer or otherwise convey the
AORN  Intellectual  Property  nor grant a license  to use the AORN  Intellectual
Property  to any  person,  firm or entity,  including  but not  limited  to, any
parent, subsidiary,  associated,  affiliated or related company. Oasis agrees to
notify AORN of any  unauthorized  use of the AORN  Intellectual  Property within
five (5) days after such unauthorized use comes to the attention of Oasis.

         All  rights  not  specifically  granted  herein  to Oasis are expressly
reserved to AORN. Such rights shall include,  but not be limited to,  derivative
works, anthology, abridgement and condensation rights, as well as all subsidiary
rights in any form of media whatsoever. If AORN requests that any portion of the
Intellectual  Property be deleted,  corrected or made inaccessible  because such
Property contains material errors,  requires updated material, or is or could be
subject  to a claim  that it is  defamatory,  obscene,  invades  the  privacy of
certain persons, or infringes any copyright, then Oasis shall take the requested
action as soon as practicable after receiving AORN's request but in no less than
thirty (30) days.

         10.  Ownership  &  Control  of  Oasis  Intellectual  Property:   "Oasis
Intellectual  Property" means all of the names,  logos,  and trademarks that are
owned  by Oasis  as well as any  information  or  materials  including,  but not
limited to, copyrighted  materials,  databases and any related programs together
with all intangible  rights associated  therewith.  AORN acknowledges and agrees
that Oasis has and will invest  substantial  time,  money and other resources in
the development of the Oasis System as well as the Oasis Intellectual  Property.
AORN acknowledges  Oasis's ownership of the Oasis System and Oasis  Intellectual
Property as well as all licensing and  copyrights to any materials  developed by
Oasis in conjunction  with the Oasis System.  All such materials  developed as a
part of the  Oasis  System  will  have  Oasis's  logo or name and AORN will have
on-going  use of such  materials.  AORN  agrees that it shall not do anything to
invalidate  any of  Oasis's  rights  and  licenses.  Nothing  contained  in this
Agreement shall give AORN any right, title or interest in the Oasis Intellectual
Property except as specifically  provided for in this Agreement.  AORN shall not
use the Oasis  Intellectual  Property  or any part  thereof  as a part of AORN's
corporate  or  trade  name  or the  corporate  or  trade  name  of  any  parent,
subsidiary,  associated, affiliated or related company. AORN agrees that it will
not take any action that would create any  confusion  in the Oasis  Intellectual
Property.  AORN  shall  not  assign,  transfer  or  otherwise  convey  the Oasis
Intellectual Property nor grant a license to use the Oasis Intellectual Property
to any  person,  firm or entity,  including  but not  limited  to,  any  parent,
subsidiary,  associated,  affiliated or related  company.  AORN agrees to notify
Oasis of any unauthorized use of the Oasis Intellectual Property within five (5)
days after such unauthorized use comes to the attention of AORN.

         11. Infringement:  In the  event  either  party  becomes  aware  of  an
infringing  use of either  AORN  Deliverables,  the Oasis  System or the AORN or
Oasis  Intellectual  Property,  such party will  notify the other  party of such
infringement immediately,  but no later than five (5) days. Upon receipt of such
notice, the parties shall meet to discuss the appropriate action including,  but
not

                                       -6-

<PAGE>

limited  to,  filing  an  action  in  federal  or  state  court to  enjoin  such
infringement. In the event either party decides not to pursue any action against
an infringing  party,  the remaining  party may pursue  whatever remedy it deems
appropriate  (at its own cost) to protect  all its rights and  interests  to its
Intellectual Property.

         12.  Confidentiality of Data and Information:  Oasis and AORN agree and
acknowledge that any and all copyrighted  materials,  data,  statistics,  client
lists and other informational materials generated by either party ("Confidential
Information"),  shall remain the property of the providing or generating  party.
None of this information  which is directly related to the AORN Deliverables may
be disclosed  or used by the  non-generating  or  providing  party for any other
purpose  other than in  connection  with the AORN  Deliverables  or as otherwise
specifically  authorized in writing by the generating or providing  party.  Upon
the  expiration or  termination  of this  Agreement,  irrespective  of the cause
thereof,  all such  information  shall be immediately  surrendered to the other,
which will retain ownership.

         13.  Indemnification:  Oasis and AORN each agree to indemnify  and hold
the other party, as well as that party's officers, members, directors, employees
or agents harmless from and against any lawsuits,  claims,  actions or causes of
action,  arising out of, or in  connection  with,  any errors or missions of the
other party,  its agents,  representatives  or  employees,  with respect to that
party's duties and obligations set forth in this Agreement:  AORN further agrees
to indemnify  and hold  harmless  Oasis with respect to any claims,  lawsuits or
actions relating to the content set forth in the  deliverables.  This obligation
includes, but is not limited to, the costs of defense,  payment of any judgments
and  payment of any  expenses  for  attorneys'  fees and other costs that may be
incurred.

         14.  Arbitration:  In  the  event  of  any  dispute  arising  out  this
Agreement,  AORN and Oasis will first seek to mediate  that  dispute.  If either
party rejects such mediation,  then AORN and Oasis agree that any controversy or
claim arising out of or relating in any way to this  Agreement  shall be settled
by arbitration  in Denver,  Colorado,  according to the  Commercial  Arbitration
Rules of the American  Arbitration  Association  ("AAA").  Any judgment or award
rendered by the arbitrator(s) shall be entered in any court having jurisdiction.
AORN and Oasis agree to pay their own out-of- pocket  expenses  associated  with
the  arbitration  including  attorneys  fees.  This provision shall not prohibit
either party from seeking  injunctive  or other relief in any court of competent
jurisdiction  to enforce  its rights in and to their  Intellectual  Property  or
Confidential Information.

         15. Compliance with Applicable Laws: Oasis represents and warrants that
it shall perform all of its duties and  responsibilities  in compliance with all
federal, state and local laws.

         16. Assignment:  Except as otherwise provided in this Agreement,  Oasis
may not assign this  Agreement or any of the rights  granted to Oasis  hereunder
without the prior written approval of AORN. Any assignment  without AORN's prior
written  approval  shall  be  void.  AORN  reserves  the  right  to  assign  any
development of its AORN  Deliverables to qualified third parties,  including but
not limited to AORN.

         17. Relationship of the Parties:  Neither party to this Agreement shall
represent  or hold  itself  out to be a  legal  representative,  joint  venture,
partner,  employee  or servant of the other party for any  purpose,  whatsoever.
Neither party is authorized to make any contract, agreement, warranty

                                       -7-

<PAGE>

or  representation  on behalf of the other  party or to create any  obligations,
express or implied, on behalf of the other party except as otherwise provided in
this Agreement.

         18. Entire  Agreement:  This  Agreement  contains the entire  agreement
between the parties with respect to this Agreement and any related transactions,
and supersedes all prior arrangements,  understandings, agreements and covenants
among the parties including,  but not limited to the Letter of Intent, dated May
12, 2000 between AORN and Oasis.

         19. Severability:  Should any term of this Agreement be declared by any
court of competent jurisdiction to be invalid for any reason, then the remainder
of this  Agreement  shall remain in full force and effect and that portion which
is determined to be invalid shall be severed.

         20. Waiver and  Amendment:  Any term or condition of this Agreement may
be waived at any time by a party entitled to the benefit  thereof if such waiver
is in writing and signed by the waiving party. A waiver of any term or provision
shall  not be  construed  as a waiver  of any other  term or  provision  of this
Agreement.  This  Agreement  may be amended at any time if such  amendment is in
writing and signed by each of the parties hereto.

         21. Governing Law:  This Agreement shall be interpreted and governed by
the laws of the State of Florida and shall be construed in accordance with those
laws.

         22.  Notice:.  Any  notice  required  or  permitted  to be given to the
parties  pursuant to the terms of this Agreement  shall be sent certified  mail,
return receipt  requested,  or by facsimile  transmission  to the parties at the
address  stated below.  All notices shall be deemed given when  deposited in the
mails, postage prepaid.

    AORN:     2170 S. Parker Road, Suite 300, Denver, CO 80231

    Oasis:    2018 Oak Terrace, Sarasota, FL 34231

         Either party may change the address at which it is to receive notice by
notifying the other party in writing of the change.

         23. Force  majeure:  Neither  party shall be deemed to be in default to
the extent  that  performance  is delayed or  prevented  by Acts of God,  public
enemy, war, civil disorder,  fire, flood, explosion,  riot, labor disputes, work
stoppages or strike, any act or order of any governmental authority or any other
cause beyond the parties control making performance impossible.

         24. Execution by Facsimile: An acceptance shall occur when both parties
are in  possession  of an original  agreement or conformed  copies signed by the
other party. If a fax transmittal is used by either party,  then a conformed fax
copy shall be treated as an original.  For record  keeping  purposes  only,  the
parties may  subsequently  exchange  signed copies of the agreement in duplicate
original so that each party shall have a signed document,  either of which shall
be deemed an original.

                                       -8-

<PAGE>

         25.    Binding Effect:.   This Agreement is binding upon and is for the
benefit of the parties and their respective successors and assigns.

         26. Headings: Paragraphs and other headings contained in this Agreement
are for reference  purposes  only, and are not intended to affect in any way the
meaning or interpretation of this agreement.

         27. Counterparts:  This agreement may be executed in counterparts, each
of which shall be deemed an original document,  but all of which will constitute
a single document.

         IN WITNESS  WHEREOF,  the  parties  have caused  this  Agreement  to be
executed as of the date first written above.

                        AORN, Inc.

                                 By
                                  ---------------------------
                                    Warren Kolber, Publisher

                                 SURGICAL SAFETY PRODUCTS, INC.

                                 By
                                   --------------------------

                                       -9-

<PAGE>

                                    EXHIBIT 1

                                AORN Deliverables

     *    AORN  Standards,  Recommended  Practices and Guidelines  ("SRPG") with
          annual updates (Quark format)

     *    AORN Journal with annual index (Quark format)

     *    AORN OR Product Directory with annual update (Access format)

     *    AORN Journal Home Studies (15  previously  published  courses)  (Quark
          format).

     *    SRPG Study Guide (Word format)

     *    AORN  Surgical  Knowledgebase.  The  AORN  Surgical  Knowledgebase  is
          currently in  development  but is expected to be available  during the
          summer of 2000.  This database will be updated  periodically.  The SKB
          database,  including;  * text and  illustration  for a minimum  of 130
          procedures  * a Patient's  Surgical  Dictionary * a review of surgical
          Internet sites * all related articles and content

within 15 days after November 31, 2000 in an Access format

The Deliverables will be provided to Oasis in their exiting formats that are set
forth above.

                                      -10-

<PAGE>

                                    EXHIBIT 2

                                AORN Deliverables

                               Annual License Fees

AORN Standards, Recommended
Practices and Guidelines                        $42,000 annual license fee

AORN Journal                                    $18,000 annual license fee

AORN OR Product Directory                       $  2,000 annual license fee

AORN Journal Home Studies (15 previously
Published courses and the SRPG Study Guide      $ 3,000 annual license fee;
                                                plus 5,000 contact hours at
                                                $6.00 per hour ($30,000). New
                                                courses can be licensed each
                                                month for $300 a course.
                                                Additional  contact hours can
                                                be purchased for $5.00 per hour.

AORN Surgical Knowledgebase.                    $22,000 annual license fee

                              Quarterly Usage Fees

(See Attached Schedule)

                                      -11-Exhibit 10.49

                                                  6 July 2000

Private and Confidential
Surgical Safety Products, Inc.
2018 Oak Terrace
Sarasota, FL  34231

         Surgical  Safety  Products,  Inc. (the  "Company") has informed  Carver
Cross Securities Corp.  ("CCSC") that the Company seeks to raise capital and has
asked CCSC to act as the  Company's  exclusive  financial  advisor and placement
agent in this  regard.  CCSC would be pleased  to assist  the  Company  and this
letter  sets forth the basis on which  CCSC will act as  financial  advisor  and
confirms the terms of CCSC's engagement as such.

         As  requested  and  in  conjunction   with  the   appropriate   Company
executives, the financial- advisory services will include:

1.   advice on the preparation of written  materials  required in presenting the
     Company to potential sources of financing;

2.   advice on the preparation of analyses of the likely  financial  performance
     and prospects of the Company;

3.   assistance  in  the  design,   presentation,   and  discussion  o  specific
     transactions to be proposed to potential  sources of financing,  addressing
     such issues as:

     *    corporate valuation; pricing of securities; and returns to investors;
     *    transaction structure; and the design of securities to be issued;
     *    non-economic terms, such as those relating to key governance issues;
     *    shareholder agreements,  including shar transfer agreements;  * voting
          agreements; and * exit strategies;

4.   identifying and approaching potential financing sources;

5.   assistance  in preparing  for and engaging in  discussions  with  potential
     financing sources;

6.   managing the process of  developing  the interest of and  negotiating  with
     potential investors,  including maintaining the pace of the process to move
     potential investors towards a closing;

7.   assistance   in   negotiating   the  terms  and   conditions  of  financing
     transactions;

8.   assistance  in  reviewing  and   negotiating   drafts  of  the   definitive
     transaction documents; and

9.   coordination of and consultation with other professional (e.g., lawyers and
     accountants) retained by the Company in the capital-raising process.

                                       -1-

<PAGE>

Surgical Safety Products, Inc.          -2-                      6 July 2000

         For its financial-advisory  services as contemplated above herein, CCSC
will be paid  financial  advisory  retainer  fees of (i) $6,000 cash plus 40,000
"Retainer  Warrants"  for the first  month  and (ii)  $2,500  cash  plus  40,000
Retainer Warrants for each month thereafter  provided,  however,  that the total
number of Retainer Warrants shall not exceed 120,000. The Retainer Warrants will
have a term of five  years  and an  exercise  price  of  $0.625  per  share.  In
addition,  CCSC shall be paid a cash  Completion  Fee relating to  financings or
financing  facilities  which are closed or signed.  The  Completion Fee shall be
equal to the sum of (a) eight  percent  (8%) of the first $5  million  of equity
capital which  financing  sources  actually  provide or commit to provide to the
Company;  plus (b) if more than $5 million is raised,  seven percent (7%) of the
amount  of  equity  capital  in excess of $5  million  which  financing  sources
actually  provide or commit to provide to the  Company;  plus (c) three  percent
(3%) of the  total  maximum  amount  of debt  capital  which  financing  sources
actually  provide or commit to provide to the Company.  The foregoing fees shall
also apply to all capital  provided to the Company for a period of two (2) years
from the date(s) of closing(s)  which give rise to a Completion  Fee pursuant to
the foregoing sentence by investors who invest in such closing(s).

         The  foregoing  paragraph  notwithstanding,   CCSC  shall  not  receive
compensation  in  respect  of  additional   draw-downs   under  the  $5  million
Convertible  Secured  Line of Credit  maturing  on 30th  November  2002 that the
Company currently has in place with Thomson Kernaghan & Co. Limited as Agent for
Lenders.

         If CCSC's efforts  pursuant hereto result in the sale of  substantially
all of the  businesses,  assets,  and/or  equity  shares  of  the  Company,  the
Completion Fee shall be four percent (4%) of the Transaction  Value,  defined as
the sum of (i) the aggregate fair market value of all cash, securities,  assets,
and  other  consideration  which  is  transferred  or to be  transferred  to the
Company,  its affiliates,  and/or its shareholders in exchange for the business,
assets,  or equity  of the  Company,  and (ii) the  amount  of  liabilities  for
borrowed money of the Company assumed by the acquirer.  If the Company effects a
public  offering,  the  Completion Fee shall be equal to two percent (2%) of the
gross proceeds from such offering.

         Immediately  after each closing of an equity  financing for the Company
in respect of which a Completion  Fee is payable,  the Company will sell to CCSC
(or  individuals/entities  designated by CCSC),  at a nominal  price,  five-year
Completion Warrants to purchase one share of the security purchased by investors
for each ten shares purchased by investors.  The per-share exercise price of the
Completion Warrants will be 101% of the price paid by the investors.

         The  Company  will  reimburse  CCSC  no less  often  than  monthly  for
reasonable  out-of-pocket  disbursements made on the Company's behalf including,
without limitation, travel, due diligence expenses, communications, research and
databases,  the fees and expenses of attorneys,  accountants,  consultants,  and
other third-party  professionals,  and the cost of publication of notices of the
transaction(s).  CCSC will adhere to the Company's travel policy which calls for
coach/business/first  class air  travel on flights  shorter  than four hours and
coach/business/first  class air travel on flights  longer than four  hours.  All
disbursements  will  be  fully  accounted  for and any  single  expense  that is
expected to exceed $1,000 will be pre-approved by the Company. Upon execution of
this letter

<PAGE>

Surgical Safety Products, Inc.               -3-                 6 July 2000

agreement,  the Company  agrees to establish a $5,000 deposit to be held by CCSC
against reimbursable expenses. This deposit will be applied to the final invoice
for expense reimbursement.  The Company will be solely responsible for all fees,
disbursements, and expenses in connection with any transaction.

Procedures and Representations

         The retainer  fees and the Company's  obligation to reimburse  CCSC for
out-of-pocket expenses are related to professional services and are unrelated to
the  consummation of a transaction,  if any. The Company agrees to remit payment
for each cash  retainer fee such that the full amount of such fee is received by
CCSC in U.S. dollars in good funds upon execution of this letter, in the case of
the first month's fee, and thereafter on the monthly  anniversaries  of the date
hereof.  (If remittance is made via bank wire transfer,  payment to CCSC will be
made without deduction for any bank fees.) Certificates  evidencing the Retainer
Warrants  will be  delivered  upon  execution  hereof  in the case of the  first
month's  Retainer  Warrants and on the two monthly  anniversaries  hereof in the
case of the second and third months' Retainer  Warrants.  Non-payment of fees in
full by the due date constitutes breach of this agreement.

         Payment for all cash  Completion  Fees will be made at closing via bank
wire transfer (without deduction for any bank fees) such that the full amount of
the Completion  Fee is credited to CCSC's account in U.S.  dollars in good funds
on the closing date;  certificates  evidencing the  Completion  Warrants will be
delivered  at closing.  The Company  agrees that no closing can be  completed or
effective  until all Completion  Fees have been paid.  Non-payment of Completion
Fees on the closing date constitutes breach of this agreement.

         As used herein above,  the term "closing"  refers to the formal closing
of a transaction pursuant to which equity investors,  corporate partners, and/or
lenders  make  capital  available  to the  Company,  and/or  execute  definitive
agreements pursuant to which the Company may receive investment capital.

         The Company agrees to remit payment for all expense  invoices such that
the full  amount of each  invoice is  received  by CCSC in U.S.  dollars in good
funds no later than ten (10) days after the date of the invoice.  (If remittance
is made via bank wire transfer,  payment to CCSC will be made without  deduction
for any bank  fees.)  Non-payment  of  expense  invoices  for more  than  twenty
calendar days after the due date constitutes breach of this agreement.

         Unpaid amounts due CCSC (fees, expense reimbursements, etc.) attract an
interest  charge of one percent  (1.0%) per month as from the statement date or,
in the case of monthly retainer fees, as from the monthly anniversaries hereof.

         The financial advisory  relationship  described herein will commence on
the  date on which  this  letter  agreement  is  executed  by the  Company.  The
financial  advisory  relationship  will be subject to a right of  termination by
either party hereto upon thirty days'  written  notice to the other party at any
time after the expiration of the "Marketing  Period." No termination will become
effective until the

<PAGE>

Surgical Safety Products, Inc.          -4-                      6 July 2000

Company has fully  reimbursed  CCSC for all outstanding  out-of-pocket  expenses
incurred on the Company's  behalf through the termination date and has paid CCSC
all  fees  due in  respect  of  periods  prior  to the  termination  date and in
connection with the termination. Upon such termination there shall be no further
obligation on the part of either party to the other, provided, however, that (i)
the  provisions   below  regarding   indemnification   shall  remain  in  effect
indefinitely, notwithstanding any termination of CCSC's engagement, and (ii) for
a period of two (2) years from the termination date the Company will continue to
have an obligation to pay Completion Fees to CCSC relating to financing provided
by sources which CCSC  introduced to the Company and/or with which CCSC assisted
the Company prior to the termination hereof.

         All contacts and negotiations  entered into by the Company prior to the
date of this  agreement  will  be  included  in the  process  conducted  by CCSC
hereunder and subject to the compensation  arrangements  herein  described.  The
Company  agrees to not make  future  contacts  or  conduct  future  negotiations
regarding the subject of this  agreement  outside the process  conducted by CCSC
for so long as this  letter  agreement  remains  in  effect.  CCSC  shall be the
Company's  exclusive  financial advisor and agent from the date hereof until the
later of (a) the expiration of the Marketing Period, and (b) such time as one of
the parties hereto  terminates this agreement in accordance with the termination
provisions set forth herein.  The Marketing Period will commence on the later of
(x) 6th  September  2000,  and (y) the date the Company,  CCSC,  and  securities
counsel formally approve the placement  memorandum and any collateral  materials
that CCSC  expects to require  during the  marketing of the Company to potential
investors and during  investors'  "due diligence"  investigation.  The Marketing
Period will expire one hundred twenty (120) days after the  commencement  of the
Marketing  Period.  The Company  recognizes that CCSC is engaged  hereunder on a
"best efforts" basis.

         The Company represents and warrants that all information previously and
hereafter  furnished  by  it or on  its  behalf  to  CCSC  (including  financial
statements  for  the  Company)  is and  shall  be  complete,  accurate,  and not
misleading.  The Company agrees to notify us promptly of any material  change in
the  Company's  businesses,  business  plans,  condition  (financial  or other),
assets, prospects, or liabilities,  whether or not such change is adverse. It is
understood  and agreed that CCSC  assumes no  responsibility  for the  accuracy,
completeness,  or fairness of information  provided by the Company and presented
to third parties.

         CCSC agrees to treat the Company's  Confidential  Information  with the
same  degree  of  care  and  confidentiality   that  CCSC  accords  confidential
information relating to its business.  CCSC agrees that, except on the Company's
instructions or with its prior consent,  CCSC will not divulge any  Confidential
Information  relating  to the  Company's  business  affairs to any third  party.
"Confidential  Information"  includes  information  that is  proprietary  to the
Company and not available from sources other than the Company.  CCSC agrees that
it  will  use  the  Confidential  Information  solely  in  connection  with  its
financial-advisory  work on the  Company's  behalf and in no event for any other
purpose whatsoever or in any way detrimental to the Company.

         In  connection  with the  engagement  of CCSC to advise  and assist the
Company with the matters set forth in this letter,  the Company hereby agrees to
indemnify and hold harmless CCSC and

<PAGE>

Surgical Safety Products, Inc.          -5-                      6 July 2000

each of CCSC's respective partners, officers, agents, and employees (each of the
foregoing  being  hereinafter  referred  to as an  "Indemnified  Person") to the
fullest  extent  permitted  by law from and against any and all losses,  claims,
damages,  expenses  (including  reasonable fees and  disbursements  of counsel),
actions   (including   shareholder    derivative   actions),    proceedings   or
investigations  (whether  formal or  informal),  or threats  thereof (all of the
foregoing being hereinafter referred to as "Liabilities"),  based upon, relating
to or arising out of any actions taken or omitted or services performed pursuant
to, or matters contemplated by, such engagement or any Indemnified Person's role
therein;  provided,  however,  that the Company  shall not be liable  under this
paragraph: (a) for any amount paid in settlement of claims without the Company's
consent,  which consent shall not be unreasonably withheld, or (b) to the extent
that a court of competent  jurisdiction finally judicially  determines that such
Liabilities  were caused by the willful  misconduct  or gross  negligence of the
Indemnified  Person  seeking   indemnification.   Neither  CCSC  nor  any  other
Indemnified Person shall have any liability to the Company related to or arising
out of the engagement described in this letter, except for liability for losses,
claims,  damages,  or  expenses  incurred  by  the  Company  which  are  finally
judicially  determined to have been caused by CCSC's willful misconduct or gross
negligence.  In  connection  with the  Company's  obligation  to  indemnify  for
expenses  as set forth  above,  the Company  further  agrees to  reimburse  each
Indemnified  Person  for  all  such  expenses  (including  reasonable  fees  and
disbursements  of counsel)  as they are  incurred  by such  Indemnified  Person;
provided, however, that if an Indemnified Person is reimbursed hereunder for any
expenses,  such reimbursement of expenses shall be refunded to the extent that a
court  of  competent   jurisdiction  finally  judicially   determines  that  the
Liabilities  in  question  were  caused  by  the  willful  misconduct  or  gross
negligence  of such  Indemnified  Person.  The rights  accorded  to  Indemnified
Persons hereunder shall be in addition to any rights that any Indemnified Person
may have at common law, by separate agreement, or otherwise.

         This letter  agreement shall be governed by and construed in accordance
with the laws of the U.S. State of New York applicable to agreements made and to
be performed entirely in such state. This letter agreement may not be amended or
otherwise  modified except by an instrument signed by both CCSC and the Company.
If any provision  hereof shall be determined to be invalid or  unenforceable  in
any respect,  such  determination  shall not affect such  provision in any other
respect or any other provision of this letter  agreement,  which shall remain in
full force and effect.

         All costs and  expenses  associated  with  enforcing  the terms of this
letter  agreement,  including any costs and expenses  associated with collecting
amounts due CCSC hereunder, shall be borne by the Company.

         This letter  agreement  supercedes all  understandings  and agreements,
whether  written  or oral,  reached  prior to the date  hereof in respect of the
matters addressed herein.

         The  Company  hereby  represents  and  warrants  that  (a) it  has  all
requisite authority to enter into this agreement,  (b) the individual  executing
this  agreement  on behalf of the  Company  is  empowered  to so do, and (c) the
Company has no agreement or fee obligation of any kind,  whether written or oral
or whether  formal or informal,  currently  in force with any  advisor,  broker,
finder,  or  similar  person or entity  relating  to  capital-raising,  mergers,
acquisitions, joint ventures, or similar transactions.

<PAGE>

Surgical Safety Products, Inc.          -6-                      6 July 2000

         If the  foregoing  accurately  sets  forth  our  understanding,  please
execute the enclosed copy of this letter below, and return same to us.

                                          Yours very truly,
                                          CARVER CROSS SECURITIES CORP.

                                          By: /s/ Bruce Carver Jackson
                                          President & Chief Executive Officer

Accepted and Agreed:
SURGICAL SAFETY PRODUCTS, INC.

By:       /s/G. Michael Swor,
            G. Michael Swor, CEO
Date:

                                       -6-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00014-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00014-of-00352.parquet"}]]